Clinical Trials on Hs-CRP

Total 373 results

Niguarda Hospital
University of Turin, Italy; Fondazione del Piemonte per l'Oncologia

Completed

Donation of Post Mortem Tumor Tissues (DONUM)

NSCLC Stage IV | CRC | CUP

Italy
GE Healthcare
PPD

Completed

A Study to Evaluate the Safety, Biodistribution, Internal Radiation Dosimetry, and Effective Dose of DaTSCAN™ Ioflupane (123I) Injection in Chinese Healthy Volunteers.

Healthy Subjects (HS)

China
Brno University Hospital
Simulation Centre of the Faculty of Medicine of Masaryk University

Completed

Simulation-based Comparative Study on Efficiency of Ventilation During Paediatric Cardiopulmonary Resuscitation (PEDIVENT)

Simulated Pediatric CRP Ventilation

Czechia
Karadeniz Technical University

Completed

Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

Menopause | CRP
Ling Cui

Completed

Fast-track Surgery After Gynecological Oncology Surgery

Postoperative Complications | Length of Stay | CRP

China
Ain Shams University

Recruiting

CRP/Albumin Ratio as a Predictive Inflammatory Marker for Postoperative SIRS and/or Sepsis

Crp

Egypt
Tourmaline Bio, Inc.

Recruiting

A Study to Evaluate TOUR006 in Patients With Chronic Kidney Disease and Elevated Hs-CRP (TRANQUILITY)

Chronic Kidney Diseases | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | C-Reactive Protein | Chronic Renal Diseases | Kidney Insufficiency, Chronic | hsCRP | High Sensitivity C-Reactive Protein | Hs-CRP

United States
Guelph Food Research Centre
University of Guelph; Glycemic Index Laboratories, Inc; Canadian Centre for Agri-Food...

Completed

A Human Trial to Assess the Low Density Lipoprotein Cholesterol (LDL-C) Lowering Effect of Soy (SOY-LDL)

Cardiovascular Disease | Hypercholesterolemia | CRP

Canada
Sigilon Therapeutics, Inc.

Withdrawn

Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy

MPS I | MPS1-S | MPS1-HS

Brazil, United Kingdom
Motus GI Medical Technologies Ltd

Terminated

Evaluation of Bowel Cleansing Using the Pure-Vu System in Patients With History of Inadequate Bowel Preparation

CRC

Israel
Baskent University

Completed

Levels of High-Sensitivity C-Reactive Protein in Heart Transplant Patients

Periodontitis | Heart Transplant Failure | Crp
Medical University of Vienna

Completed

Flowchart-Assisted Resuscitation. Standard CPR vs. Chest Compressions Only: What Happened to the Quality?

CPR Guidelines
LivaNova

Completed

Optimization With SonR Method in the ClinicAl pRactice (OSCAR)

CRT Patients

Spain, France, Germany, Austria, Italy, Portugal
Chinese University of Hong Kong

Withdrawn

Effect of WhatsApp Messenger on Uptake of CRC Screening Study

CRC

Hong Kong
Helsinki University Central Hospital

Completed

Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome (MultiModCRPS)

CRPS

Finland
Motus GI Medical Technologies Ltd

Completed

Clinical Investigational Plan: Evaluation of the Performance of the Motus Cleansing System

CRC

Israel
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

CRC

Spain
Children's Hospital of Philadelphia
Laerdal Medical

Completed

Q-CPR Compression Sensor Size Qualification in Children (PUCK)

CPR

United States
TC Erciyes University

Active, not recruiting

The Effect of Oral Whey Consumption on Insulin Resistance, Cortisol, Crp, Albumin Level and Healing Quality Before Total Hip Arthroplasty (WHEY THA)

Quality of Life | Insulin Resistance | Cortisol; Hypersecretion | Crp | Albus; Lichen

Turkey
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (STOP-HS1)

Hidradenitis Suppurativa (HS)

United States, Canada, Czechia, Spain, Germany, Poland, Netherlands, Belgium, France, Greece, Japan, Austria
Shanghai Henlius Biotech

Not yet recruiting

Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC

CRC
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Performance of the Motus Cleansing System (MCS) (MCS)

CRC

Netherlands, Germany
Motus GI Medical Technologies Ltd

Completed

Evaluation of the Motus GI CleanUp System During Screening Colonoscopy

CRC
Geisinger Clinic

Recruiting

Clinical and Radiographic Success of MTA vs Biodentine

Pulpotomy | Indirect Pulp Cap

United States
The Netherlands Cancer Institute
Erasmus Medical Center; Amsterdam University Medical Centres (AUMC)

Active, not recruiting

Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening (mtFIT)

CRC | Advanced Neoplasia

Netherlands
Rinovum Women's Health, Inc.

Completed

Human Factors Usability Study of Ib2C Conception System

Cervical Cap Insemination

United States
Boehringer Ingelheim

Recruiting

A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab

Hidradenitis Suppurativa (HS)

Canada
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS) (STOP-HS2)

Hidradenitis Suppurativa (HS)

United States, Canada, Bulgaria, Italy, Spain, Germany, Poland, France, Australia, Denmark, United Kingdom
Novartis Pharmaceuticals

Available

Secukinumab Global MAP Cohort for Adult Patients With Hidradenitis Suppurativa (HS)

Hidradenitis Suppurativa (HS)
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis Suppurativa (PIONEER I)

Hidradenitis Suppurativa (HS)
InflaRx GmbH
Quintiles, Inc.

Completed

Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS) (SHINE)

Hidradenitis Suppurativa (HS)

United States, Bulgaria, Canada, Denmark, France, Germany, Greece, Netherlands, Poland
University Ghent

Completed

Physiological Responses During Sustained CPR.

Sustained CPR
Jacobio Pharmaceuticals Co., Ltd.

Recruiting

FIH Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation in China

NSCLC | Solid Tumor | CRC

China
Midwest Orthopaedics at Rush

Unknown

A Prospective RSA and Clinical Evaluation of the Trident II Acetabular Cup

Total Hip Arthroplasty | Acetabular Cup

United States
Incyte Corporation

Recruiting

A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa (STOP-HS LTE)

Hidradenitis Suppurativa (HS)

United States, Austria, Belgium, Canada, Germany, Poland, Spain, Australia, Denmark, France, United Kingdom, Japan, Bulgaria, Netherlands, Czechia, Greece, Italy
Association pour la Recherche Clinique et Immunologique

Not yet recruiting

The Role of Host-microbiota Interplay in Hidradenitis Suppurativa Pathogenesis (VERIMMUNE)

Hidradenitis Suppurativa (HS)

France
Association pour la Recherche Clinique et Immunologique

Not yet recruiting

Autophagy Dysfunction in Hidradenitis Suppurativa (AUTOPH-HS)

Hidradenitis Suppurativa (HS)
AbbVie

Completed

A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms

Hidradenitis Suppurativa (HS)

United States, Canada, Japan, Puerto Rico
AbbVie

Completed

Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa (HS)

Japan
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis Suppurativa (PIONEER II)

Hidradenitis Suppurativa (HS)
AbbVie

Completed

Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects (HS rPMS)

Hidradenitis Suppurativa (HS)

Korea, Republic of
AbbVie

Completed

Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness (SOLACE)

Hidradenitis Suppurativa (HS)

Canada
jianming xu
KAEDI

Recruiting

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Solid Tumor | CRC

China
Biotronik SE & Co. KG

Completed

TD01 Master Study (Safety and Efficacy Study)

ICD/CRT-D Indication

Germany, Austria
Chang Gung Memorial Hospital

Completed

Systemic Effects After Local Injection of Platelet-rich Plasma

Platelet Rich Plasma (PRP)

Taiwan
AbbVie

Completed

Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS)

Hidradenitis Suppurativa (HS)

United States, Belgium, Canada, Colombia, Czechia, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Spain, Sweden, Turkey, United Kingdom
Hasan Kalyoncu University

Recruiting

The Effect of Blended E-Learning Method on Students' Knowledge and Psychomotor Skills on Basic Life Support

Qualified CPR Education

Turkey
SparX Biotech(Jiangsu) Co., Ltd.

Recruiting

A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors (SPX-303)

Solid Tumor | CRC | HNSCC | RCC

United States
InventisBio Co., Ltd
Merck Sharp & Dohme LLC

Active, not recruiting

Study to Evaluate D-1553 in Subjects With Solid Tumors

NSCLC | Solid Tumor, Adult | CRC

United States, Taiwan, Australia, Korea, Republic of
Wake Forest University Health Sciences

Active, not recruiting

Hidradenitis Suppurativa Wound Care

Hidradenitis Suppurativa (HS)

United States

Clinical Trials on Hs-CRP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations